News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Walvax Will Spend $112 Million to Up Vaccine Capacity



6/29/2011 10:35:33 AM

June 29, 2011 -- Walvax Biotechnology has received board approval for a 727 million RMB ($112 million) building project. The money will be used to finance construction of the third phase of the company’s production facility in Yunnan province. Walvax, a vaccine manufacturer, completed a very successful IPO on the ChiNext exchange in November 2010, raising $358 million. More details....

Stock Symbol: (SHE: 300142)


Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES